SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Naspers Limited (NPSNY) trades at a trailing P/E of 1.8, forward P/E of 11.4. Trailing earnings yield is 54.35%, forward earnings yield 8.76%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (1.8); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (54.35%).
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 54.35% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 76/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NPSNY
Valuation Multiples
P/E (TTM)1.8
Forward P/E11.4
PEG Ratio0.02
Forward PEG0.60
P/B Ratio0.00
P/S Ratio1.34
EV/EBITDA0.0
Per Share Data
EPS (TTM)$6.10
Forward EPS (Est.)$0.98
Book Value / Share$0.00
Revenue / Share$8.40
FCF / Share$0.00
Yields & Fair Value
Earnings Yield54.35%
Forward Earnings Yield8.76%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.46 |
$5.93B |
$994M |
16.8% |
| 2016 |
$1.07 |
$6.1B |
$2.92B |
47.9% |
| 2017 |
$5.26 |
$6.66B |
$11.36B |
170.5% |
| 2018 |
$3.15 |
$3.29B |
$6.9B |
209.7% |
| 2019 |
$1.38 |
$4B |
$3.1B |
77.4% |
| 2020 |
$2.41 |
$5.93B |
$5.3B |
89.4% |
| 2021 |
$8.25 |
$7.94B |
$12.22B |
153.9% |
| 2022 |
$4.00 |
$6.78B |
$4.33B |
63.9% |
| 2023 |
$3.06 |
$6.43B |
$2.86B |
44.4% |
| 2025 |
$6.10 |
$7.18B |
$5.24B |
73% |
